Hypoglycemia and Cortisol Deficiency Associated With Low-dose Corticosteroid Therapy for Asthma
1 Department of Pediatrics, University of Wisconsin Children's Hospital, Madison, WI 53792
2 Division of Pediatric Allergy, University of Wisconsin Children's Hospital, Madison, WI 53792
3 Division of Pediatric Endocrinology, University of Wisconsin Children's Hospital, Madison, WI 53792
Glucocorticoids are a cornerstone of the anti-inflammatory treatment of asthma. To minimize adverse effects of oral glucocorticoids (OGC), clinicians have used alternate-day oral or inhaled corticosteroids (IC), both generally considered safe for chronic asthma therapy in children. Although reversible growth suppression occasionally occurs, the general consensus is that, despite detectable biochemical alterations, these modes of therapy are not associated with clinically significant adrenal insufficiency.1 We report the occurrence of hypoglycemia due to cortisol deficiency during combination alternate-day oral and inhaled corticosteroids.
CASE HISTORY
A 3
-year-old boy with asthma was found one morning to be unarousable, limp, and blue around the lips.
This article has been cited by other articles:
![]() |
F. Caballero-Fonseca, M. Sanchez-Borges, and G. R.G. Todd Adrenal Suppression Related to Inhaled Corticosteroids Revisited Chest, September 1, 2002; 122(3): 1103 - 1104. [Full Text] [PDF] |
||||





